PSYCHOTHERAPY FOR ADOLESCENTS, CHildren AND ADULTS
Filmmaker Courtney Stephens discusses her documentary on the controversial scientist John C. Lilly.
Lilly was an American scientist who invented the sensory deprivation tank, studied cetacean communication, and experimented with LSD and ketamine—sometimes all at the same time.
Read moreThis development underscores MindBio’s commitment to advancing psychedelic medicine as a viable option for mental health treatment.
Read moreThe government finally fast-tracked LSD as an anxiety treatment.
MindMed, the first publicly traded pharmaceutical company focused on psychedelics, said its drug has received a breakthrough designation from the FDA.
Read moreDifferent psychedelics show unique promise for treating mental illness, from PTSD to depression and anxiety. This article compares MDMA and LSD.
Read moreThis study, published in the Journal of Psychopharmacology, found that LSD “not only increases the strength of certain brain connections but weakens other connections at the same time,” according to a digest of the study in Psychedelic Spotlight.
Read moreThe link between psychosis model and therapeutic model seems to lie in mystical experiences.
The results point to the importance of meaning attribution for the LSD psychosis model and indicate that psychedelic-assisted therapy might benefit from therapeutic suggestions fostering mystical experiences.
Read moreA new study on microdosing LSD did not find any beneficial long-term changes in mood or cognition.
Read moreIn a newly published study, researchers look at what happens to your brain on LSD.
Read moreShe was a personal acquaintance of Albert Hofmann, the scientist who first synthesised LSD and noted its psychedelic effects 80 years ago, in April 1943.
Read morePositive changes were observed across all 17 outcome items, with the strongest benefits on items related to insight and mood. Negative effects were reported by 22.5% of respondents.
High intensity of psychedelic experience, seeking advice before treatment, treating with psilocybin mushrooms and treating post-traumatic stress disorder were associated with higher scores on the self-treatment outcome scale after averaging values across all 17 items.
Younger age, high intensity of experience and treating with LSD were associated with increased number of negative outcomes.
Read more